Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward-Reference-Cited by-同舟云学术

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward

Published:2020-01 Issue:1 Volume:16 Page:229-243
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's Dement.

Author:

Alber Jessica¹²³⁴,Goldfarb Danielle⁵,Thompson Louisa I.³⁴,Arthur Edmund¹²⁴,Hernandez Kimberly⁶,Cheng Derrick⁷,DeBuc Delia Cabrera⁸,Cordeiro Francesca⁹¹⁰¹¹,Provetti-Cunha Leonardo¹²¹³¹⁴,den Haan Jurre¹⁵,Van Stavern Gregory P.¹⁶,Salloway Stephen P.³⁴¹⁷,Sinoff Stuart¹⁸,Snyder Peter J.¹²¹⁹

Affiliation:

1. Department of Biomedical and Pharmaceutical Sciences; University of Rhode Island; Kingston Rhode Island USA

2. George and Anne Ryan Institute for Neuroscience; University of Rhode Island; Kingston Rhode Island USA

3. Department of Psychiatry and Human Behavior; Alpert Medical School of Brown University; Providence Rhode Island USA

4. Butler Hospital Memory & Aging Program; Providence Rhode Island USA

5. Banner Alzheimer's Institute; Phoenix Arizona USA

6. Women & Infants Hospital; Providence Rhode Island USA

7. Alpert Medical School of Brown University; Providence Rhode Island USA

8. Department of Ophthalmology, Bascom Palmer Eye Institute; University of Miami; Miami Florida USA

9. Imperial College London; London UK

10. University College London; London UK

11. Western Eye Hospital; London UK

12. Federal University of Juiz de Fora Medical School; Juiz de Fora Minas Gerais Brazil

13. Juiz de Fora Eye Hospital; Juiz de Fora Minas Gerais Brazil

14. University of São Paulo Medical School; São Paulo Brazil

15. Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam; Amsterdam UMC Amsterdam the Netherlands

16. Department of Ophthalmology and Visual Sciences; Washington University in St. Louis School of Medicine; St. Louis Missouri USA

17. Department of Neurology; Alpert Medical School of Brown University; Providence Rhode Island USA

18. BayCare Health; Clearwater Florida USA

19. Department of Neurology and Department of Surgery (Ophthalmology); Alpert Medical School of Brown University; Providence Rhode Island USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/alz.12006/fullpdf

Reference133 articles.

1. Brookmeyer R Abdalla N Kawas CH Corrada M https://doi.org/10.1016/j.jalz.2017.10.009

2. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease;Sperling;Alzheimer's Dement,2011

3. NIA-AA research framework: toward a biological definition of Alzheimer's disease;Jack;Alzheimer's Dement,2018

4. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers;Jack;Lancet Neurol,2013

5. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade;Jack;Lancet Neurol,2010

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies;Signal Transduction and Targeted Therapy;2024-08-23

2. Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic;Alzheimer's Research & Therapy;2024-08-21

3. Alzheimer's disease stage recognition from MRI and PET imaging data using Pareto-optimal quantum dynamic optimization;Heliyon;2024-08

4. Age-Related Retinal Layer Thickness Changes Measured by OCT in APPNL-F/NL-F Mice: Implications for Alzheimer’s Disease;International Journal of Molecular Sciences;2024-07-27

5. Retinal Vascular and Structural Changes in the Murine Alzheimer’s APPNL-F/NL-F Model from 6 to 20 Months;Biomolecules;2024-07-10